Quantile‐specific heritability of plasminogen activator inhibitor type‐1 (PAI‐1, aka SERPINE1) and other hemostatic factors

2021 ◽  
Author(s):  
Paul T Williams
Keyword(s):  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Hemostatic Factors ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

Induction of Plasminogen Activator Inhibitor Type-1 (PAI-1) by Proinsulin and Insulin In Vivo

Circulation ◽  
1995 ◽  
Vol 91 (3) ◽  
pp. 764-770 ◽  
Author(s):  
Thomas K. Nordt ◽  
Hirofumi Sawa ◽  
Satoshi Fujii ◽  
Burton E. Sobel
Keyword(s):  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina

2004 ◽  
Vol 91 (05) ◽  
pp. 1026-1030 ◽  
Author(s):  
Hidetomo Maruyoshi ◽  
Tohru Funahashi ◽  
Shinzo Miyamoto ◽  
Jun Hokamaki ◽  
Hirofumi Soejima ◽  
...  
Keyword(s):  
Plasminogen Activator ◽  
Plasma Levels ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Exertional Angina ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

SummaryAdipose tissue is a secretory organ producing a variety of bioactive substances, such as adiponectin. Adiponectin has antiatherogenic properties while plasminogen activator inhibitor type 1 (PAI-1) is closely involved in the development of atherosclerosis. The relationship between adiponectin and PAI-1 in patients with coronary artery disease (CAD) has not been clarified. This study examined plasma levels of adiponectin and PAI-1 in 64 patients with stable exertional angina (SEA) and 65 patients with the chest pain syndrome (CPS). Plasma logadiponectin levels were significantly lower in patients with SEA (0.62±0.08 µg/dL) compared to those with CPS (0.86± 0.05 µg/dL) (p<0.0001). The plasma levels of log-PAI-1 were significantly higher in patients with SEA (1.23±0.18 ng/mL) compared to those with CPS (1.15±0.22 ng/mL) (p<0.05). Plasma log-adiponectin levels correlated negatively with diabetes mellitus (DM), body mass index (BMI), log-PAI-1 (r=−0.284, p<0.001), triglyceride (TG), and remnant-like particles cholesterol (RLP-C), and positively with high-density lipoprotein cholesterol (HDL-C) levels. Plasma levels of log-PAI-1 correlated positively with DM, BMI, TG and RLP-C levels, and negatively with HDL-C levels. Multiple logistic regression analysis identified sex, angina pectoris, and PAI-1 as independent determinants of hyperadiponectinemia (p<0.05). Adiponectin is inversely related to PAI-1. DM, BMI, TG, HDL-C, and RLP-C are common mediators between adiponectin and PAI-1, and treatment for common mediators may prevent the development of CAD by reducing PAI-1 and increasing adiponectin levels.

540 Plasminogen Activator Inhibitor Type-1 (PAI-1) Gene 4G/5G Polymorphism and Genetic Tendency to Colon Cancer

2012 ◽  
Vol 48 ◽  
pp. S128
Author(s):  
B. Badak ◽  
S. Erkasap ◽  
N. Erkasap ◽  
B. Bayram ◽  
M. Ozkurt ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

Non-muscle α-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1)

2004 ◽  
Vol 385 (9) ◽  
Author(s):  
Ulla Magdolen ◽  
Florian Schroeck ◽  
Sabine Creutzburg ◽  
Manfred Schmitt ◽  
Viktor Magdolen
Keyword(s):  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 (PAI-1), ORGAN FAILURE AND OUTCOME AFTER SUCCESSFUL CARDIOPULMONARY RESUSCITATION (CPR)

1999 ◽  
Vol 27 (Supplement) ◽  
pp. A66
Author(s):  
Alexander Geppert ◽  
Gerlinde Zorn ◽  
Georg Delle Karth ◽  
Gottfried Heinz ◽  
Peter Siostrzonek ◽  
...  
Keyword(s):  
Cardiopulmonary Resuscitation ◽  
Organ Failure ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

Analysis of plasminogen activator inhibitor type 1 (PAI-1) by light spectroscopy: attempts to determine intra-molecular distances

1994 ◽  
Vol 8 ◽  
pp. 103
Author(s):  
S.B. Aleshkav ◽  
M. Fa ◽  
J. Karolin ◽  
L. Strandberg ◽  
L.B.Å. Johansson ◽  
...  
Keyword(s):  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

Investigation of Association between Plasminogen Activator Inhibitor Type-1 (PAI-1) Gene 4G/5G Polymorphism Frequency and Plasma PAI-1 Enzyme Activity in Patients with Acute Stroke

2008 ◽  
Vol 12 (3) ◽  
pp. 443-451 ◽  
Author(s):  
Banu Kucukarabaci ◽  
Hasan Veysi Gunes ◽  
Gazi Ozdemir ◽  
Didem Cosan ◽  
Demet Ozbabalik ◽  
...  
Keyword(s):  
Enzyme Activity ◽  
Acute Stroke ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1

Thrombolysis failure: a role for plasminogen activator inhibitor type 1 (PAI-1)

2001 ◽  
Vol 113 (2) ◽  
pp. 559-560 ◽  
Author(s):  
Stephen C. Nicholls ◽  
Wayne L. Chandler ◽  
Eric K. Hoffer
Keyword(s):  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Plasminogen Activator Inhibitor Type ◽  
Inhibitor Type ◽  
Activator Inhibitor Type ◽  
Activator Inhibitor ◽  
Pai 1
Sign in / Sign up

Export Citation Format

Share Document